Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Cancer
|
September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
Sara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Nature Communications
|
January 3, 2024
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity
Elisa Landoni, Mark G Woodcock, Gabriel Barragan, et al.
International Journal of Molecular Sciences
|
July 29, 2025
CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy
Maria Grazia Ceraolo, Marika Milan, Nicole Fratini, et al.
Cancer Immunology Research
|
February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling
Elisa Landoni, Giovanni Fucá, Jian Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Cell
|
December 1, 2023
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
Elisa Bergaggio, Wei-Tien Tai, Andrea Aroldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Blood
|
June 23, 2017
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Sara Mastaglio, Pietro Genovese, Zulma Magnani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 11, 2026
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity
Gabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.
The Journal of Pathology
|
November 11, 2024
Macrophages producing chondroitin sulfate proteoglycan-4 induce neuro-cardiac junction impairment in Duchenne muscular dystrophy
Marika Milan, Fabio Maiullari, Maila Chirivì, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Cancer
|
September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
Sara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Nature Communications
|
January 3, 2024
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity
Elisa Landoni, Mark G Woodcock, Gabriel Barragan, et al.
International Journal of Molecular Sciences
|
July 29, 2025
CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy
Maria Grazia Ceraolo, Marika Milan, Nicole Fratini, et al.
Cancer Immunology Research
|
February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling
Elisa Landoni, Giovanni Fucá, Jian Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Cell
|
December 1, 2023
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
Elisa Bergaggio, Wei-Tien Tai, Andrea Aroldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Blood
|
June 23, 2017
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Sara Mastaglio, Pietro Genovese, Zulma Magnani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 11, 2026
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity
Gabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.
The Journal of Pathology
|
November 11, 2024
Macrophages producing chondroitin sulfate proteoglycan-4 induce neuro-cardiac junction impairment in Duchenne muscular dystrophy
Marika Milan, Fabio Maiullari, Maila Chirivì, et al.
Page
of 3